News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,188 Results
Type
Article (58058)
Company Profile (611)
Press Release (705519)
Section
Business (218583)
Career Advice (2830)
Deals (37922)
Drug Delivery (119)
Drug Development (86527)
Employer Resources (181)
FDA (17673)
Job Trends (16248)
News (372636)
Policy (37300)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2916)
Academic (1)
Accelerated approval (3)
Adcomms (25)
Allergies (83)
Alliances (53902)
ALS (87)
Alzheimer's disease (1426)
Antibody-drug conjugate (ADC) (123)
Approvals (17637)
Artificial intelligence (269)
Autoimmune disease (14)
Automation (14)
Bankruptcy (387)
Best Places to Work (12426)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (422)
Bladder cancer (57)
Brain cancer (28)
Breast cancer (255)
Cancer (1960)
Cardiovascular disease (160)
Career advice (2375)
Career pathing (32)
CAR-T (150)
Cell therapy (421)
Cervical cancer (16)
Clinical research (69638)
Collaboration (778)
Compensation (439)
Complete response letters (29)
COVID-19 (2837)
CRISPR (40)
C-suite (202)
Cystic fibrosis (102)
Data (1827)
Decentralized trials (2)
Denatured (27)
Depression (45)
Diabetes (250)
Diagnostics (6752)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (124)
Drug pricing (119)
Drug shortages (32)
Duchenne muscular dystrophy (76)
Earnings (90062)
Editorial (37)
Employer branding (21)
Employer resources (157)
Events (119679)
Executive appointments (647)
FDA (18746)
Featured Employer (60)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (701)
Gene editing (102)
Generative AI (28)
Gene therapy (298)
GLP-1 (767)
Government (4925)
Grass and pollen (4)
Guidances (47)
Healthcare (20352)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (106)
Indications (25)
Infectious disease (2974)
Inflammatory bowel disease (141)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (77)
Interviews (500)
IPO (17305)
IRA (49)
Job creations (4322)
Job search strategy (1995)
Kidney cancer (10)
Labor market (30)
Layoffs (502)
Leadership (19)
Legal (9291)
Liver cancer (76)
Lung cancer (283)
Lymphoma (130)
Machine learning (2)
Management (63)
Manufacturing (286)
MASH (62)
Medical device (14273)
Medtech (14278)
Mergers & acquisitions (21047)
Metabolic disorders (669)
Multiple sclerosis (67)
NASH (18)
Neurodegenerative disease (82)
Neuropsychiatric disorders (27)
Neuroscience (1916)
NextGen: Class of 2025 (7352)
Non-profit (4957)
Northern California (2323)
Now hiring (36)
Obesity (369)
Opinion (251)
Ovarian cancer (67)
Pain (83)
Pancreatic cancer (74)
Parkinson's disease (132)
Partnered (17)
Patents (198)
Patient recruitment (91)
Peanut (49)
People (61013)
Pharmaceutical (127)
Pharmacy benefit managers (21)
Phase I (21580)
Phase II (30433)
Phase III (22897)
Pipeline (883)
Podcasts (83)
Policy (125)
Postmarket research (3035)
Preclinical (9267)
Press Release (71)
Prostate cancer (89)
Psychedelics (34)
Radiopharmaceuticals (262)
Rare diseases (381)
Real estate (6629)
Recruiting (70)
Regulatory (25108)
Reports (45)
Research institute (2594)
Resumes & cover letters (463)
Rett syndrome (3)
RNA editing (2)
RSV (45)
Schizophrenia (71)
Series A (123)
Series B (76)
Service/supplier (25)
Sickle cell disease (55)
Southern California (2034)
Special edition (18)
Sponsored (31)
Startups (3967)
State (2)
Stomach cancer (15)
Supply chain (63)
The Weekly (55)
United States (21224)
Vaccines (740)
Venture capitalists (36)
Webinars (12)
Weight loss (266)
Women's health (31)
Worklife (16)
Date
Today (122)
Last 7 days (562)
Last 30 days (3026)
Last 365 days (36246)
2025 (7155)
2024 (37459)
2023 (42038)
2022 (53393)
2021 (58162)
2020 (57041)
2019 (50262)
2018 (38243)
2017 (35329)
2016 (35344)
2015 (41224)
2014 (35188)
2013 (30571)
2012 (32688)
2011 (33303)
2010 (31428)
Location
Africa (976)
Alabama (52)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (44316)
Australia (7421)
California (5460)
Canada (1839)
China (455)
Colorado (248)
Connecticut (274)
Delaware (129)
Europe (97752)
Florida (796)
Georgia (192)
Hawaii (1)
Idaho (60)
Illinois (524)
India (23)
Indiana (302)
Iowa (9)
Japan (137)
Kansas (104)
Kentucky (26)
Louisiana (10)
Maine (60)
Maryland (866)
Massachusetts (4219)
Michigan (216)
Minnesota (376)
Mississippi (2)
Missouri (81)
Montana (31)
Nebraska (25)
Nevada (56)
New Hampshire (67)
New Jersey (1549)
New Mexico (31)
New York (1545)
North Carolina (994)
North Dakota (8)
Northern California (2323)
Ohio (190)
Oklahoma (14)
Oregon (44)
Pennsylvania (1217)
Puerto Rico (7)
Rhode Island (27)
South America (1361)
South Carolina (17)
South Dakota (1)
Southern California (2034)
Tennessee (90)
Texas (815)
Utah (166)
Virginia (141)
Washington D.C. (63)
Washington State (529)
West Virginia (3)
Wisconsin (59)
764,188 Results for "actelion pharmaceuticals us inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Layoffs
Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees
Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.
February 28, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
March 7, 2025
·
4 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
February 13, 2025
·
1 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
March 13, 2025
·
6 min read
Press Releases
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
February 6, 2025
·
9 min read
Press Releases
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
March 17, 2025
·
4 min read
BioCapital
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has acquired U.S. and Canadian rights to PONVORY ® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company. PONVORY ® is approved by the U.S. Food and Drug Administration (FDA) and Health Canada to treat adults with relapsing forms of multiple sclerosis .
December 7, 2023
·
9 min read
Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal
Under an agreement with Johnson & Johnson’s Actelion Pharmaceuticals, the rights to the multiple sclerosis drug Ponvory in the U.S. and Canada will be transferred to Vanda Pharmaceuticals.
December 8, 2023
·
2 min read
·
Tyler Patchen
GLP-1
Altimmune Jumps On Takeover Rumors After Launching Alcohol Use Disorder Study
The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and alcohol-related liver disease.
March 17, 2025
·
1 min read
·
Tristan Manalac
1 of 76,419
Next
